Back

APOE4/4 is linked to damaging lipid droplets in Alzheimer's microglia

Haney, M.; Palovics, R.; Munson, C.; Long, C.; Johansson, P.; Yip, O.; Dong, W.; Rawat, E.; West, E.; Schlachetzki, J.; Tsai, A. P.-Y.; Guldner, I.; Lamichhane, B.; Smith, A.; Schaum, N.; Calcuttawala, K.; Shin, A.; Wang, Y.-H.; Wang, C.; Koutsodendris, N.; Serrano, G. E.; Beach, T.; Reiman, E. M.; Glass, C.; Abu-Remaileh, M. M.; Enejder, A.; Huang, Y.; Wyss-Coray, T.

2023-07-25 neuroscience
10.1101/2023.07.21.549930 bioRxiv
Show abstract

Several genetic risk factors for Alzheimers Disease (AD) implicate genes involved in lipid metabolism and many of these lipid genes are highly expressed in glial cells. However, the relationship between lipid metabolism in glia and AD pathology remains poorly understood. Through single-nucleus RNA-sequencing of AD brain tissue, we have identified a microglial state defined by the expression of the lipid droplet (LD) associated enzyme ACSL1 with ACSL1-positive microglia most abundant in AD patients with the APOE4/4 genotype. In human iPSC-derived microglia (iMG) fibrillar A{beta} (fA{beta}) induces ACSL1 expression, triglyceride synthesis, and LD accumulation in an APOE-dependent manner. Additionally, conditioned media from LD-containing microglia leads to Tau phosphorylation and neurotoxicity in an APOE-dependent manner. Our findings suggest a link between genetic risk factors for AD with microglial LD accumulation and neurotoxic microglial-derived factors, potentially providing novel therapeutic strategies for AD.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.